San Diego-based mostly Viking Therapeutics marked itself as a serious competitor during the weight loss drug marketplace in February following revealing promising details from the mid-stage demo of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when supplied being a weekly injection As well as in Marc